Editas Medicine Inc (NASDAQ: EDIT): Analyst View Points To Future Growth
Editas Medicine Inc (EDIT) concluded trading on Wednesday at a closing price of $2.05, with 9.1 million shares of worth about $18.65 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.19% during that period and on March 05, 2025 the price saw a […]
Better Times Ahead For Editas Medicine Inc (NASDAQ: EDIT)?
Editas Medicine Inc (EDIT) concluded trading on Thursday at a closing price of $1.83, with 7.76 million shares of worth about $14.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -53.32% during that period and on February 27, 2025 the price saw a […]
Look For Institutional Buying In Editas Medicine Inc (NASDAQ: EDIT)
The Vanguard Group, Inc. has recently announced that it has increased stake in Editas Medicine Inc (NASDAQ:EDIT) by 4.53%. After grabbing 8.41 million shares, the institutional investor is now in possession of 0.36 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 10.30% having worth around $88.58 million. […]
